
Time to unlock

BE FINANCIALLY INDEPENDENT

The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Latent view IPO– Latent view is incorporated in 2006, Company provides services ranging from data analytics consulting to business analytics and insights, advanced predictive analytics, data engineering and digital solutions to companies in technology, BFSI, CPG and retail, industrials and other industries.
Business — Four Major domains -> (i) Consulting services (ii) Data engineering (iii) Business analytics (iv) Digital solutions
Region of Operation -It serves clients across the US, Europe, and Asia through its subsidiaries in the US, Netherlands, Germany, UK and Singapore.
Also READ : NYKAA IPO : SUBSCRIBE OR NOT
Offer purpose — The IPO comprises a fresh issue of equity shares up to ₹474 crore and an offer for sale (OFS) of ₹126 crore by existing shareholders and promoters. Company plans to use about ₹148 crore to fund inorganic growth initiatives, ₹130 crore for investment in subsidiaries and the remaining to fund working capital and general corporate purposes.
Risks —
Client Concentration
Regional Concentration
Technology disruption Risk
Strength
Future
Company has created a niche place in data analytics services globally and It caters to Fortune 500 companies with long term relationships and it is also able to maintain healthy margins on its contracts
Valuations
Valuations are high
Should we apply?
Looks almost priced in at IPO price but for medium to long term, prospects looks bright.
One can apply if can held this stock patiently and not looking for immediate returns
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.

Read more for these IPO before listing on their business, strength, risks Bector Food , Happiest minds, Route mobile, Rossari biotech, Burger king

The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Chemcon– is a manufacturer of specialized chemicals, such as HMDS (Hexamethyl Disilazane) and CMIC (Chloromethyl Isopropyl Carbonate) and is market leader in both products. This are predominantly used in the pharmaceuticals industry, and inorganic bromides, namely Calcium Bromide, Zinc Bromide and Sodium Bromide, which are used as completion fluids in the oilfields industry
Offer purpose — 318cr Complete offer for sale by promoters
Key Service domains – Pharmaceuticals and oilfields industry
Clients -Hetero Labs Limited, Laurus Labs Limited, Aurobindo Pharma Limited, Sanjay Chemicals (India) Private Limited, and the key customers of Oilwell Completion Chemicals include Shree Radha Overseas, Water Systems Specialty Chemical DMCC, Universal Drilling Fluids and CC Gran Limited Liability Company.
Revenues from Key Clients— 67%
Revenues from Key regions–32% exports
Risks —
Limited product range
Significant portion from few customers
Promoters past is the biggest risk. There are cases of non-compliance and criminal proceedings
Future
Company has grown revenues and profits and partially supported by ban of chemicals in China to support environmental policies
Due to specialty chemicals and market leader, company stands at good point to gain
Valuations
Reasonable considering peers in India in specialty chemicals. Fundamentals seems promising as of now
Should we apply?
Less chances of allotment due to small size. People who understand chemical business well can take the risk of applying
Less risk taking people can avoid
Listing day may see see moderate gains . Recommended to book profits if any on listing day
Keep an eye on promoter walk the talk scenario if holding for long
Also Read
Happiest Minds IPO crisp summary –Listing with substantial gains
Route Mobile IPO crisp Summary — Listing with substantial gains
Rossari biotech IPO detailed summary –Listed with substantial gains
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.
The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
CAMS– almost two decades of experience –is a technology-driven financial infrastructure and services provider to mutual funds and other financial institutions. Aggregate market share of approximately 70% based on mutual fund average assets under management (“AAUM”) managed by their clients and serviced by us
Offer purpose — 2258cr Complete offer for sale by promoters
Key Service domains – Mutual funds, AIF business, KYC registration, Insurance services business
Clients -SBI Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, and Aditya Birla Sun Life Mutual Fund are serviced by CAMS
Revenues from Key Business— 85% ( mutual funds)
Risks —
Huge dependency on Mutual fund business with major revenue from it (more than 85%)
Significant disruptions in information technology systems can cause it a loss
Slow revenue growth in past few years
Risk of Regulators.
Pricing power can be a hurdle to grow earnings
Future
Long term growth seems reasonable and demand seems to increase in coming years with Indian Mutual fund industry set to grow
Almost all Major mutual funds are clients
Valuations
Expensive but considering almost duopoly, it can undergo time correction
Should we apply?
High chances of allotment. Less Risk taking people can avoid
Listing day can see (-8%) to 20% . Recommended to book profits if any on listing day
3+ year holding can give good returns even from this price if things workout well
Also Read
Happiest Minds IPO crisp summary –Listing with substantial gains
Route Mobile IPO crisp Summary — Listing with substantial gains
Rossari biotech IPO detailed summary –Listed with substantial gains
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.
The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Route Mobile– almost 16 yr old company –technology service provider specializing in communication services to enterprises. Acts as communication platform as a service
Offer purpose — 360cr as offer for sale by promoters and 240 cr as fresh issue. so 40% will flow to company to reduce loans, acquire companies etc
Key Service domains – Messaging services and Call center services
Clients -ICICI Bank, State Bank of India, Skype, Emirates Airlines, Bank of Maharashtra, WeChat, OSN and Viber.
Revenues from Key regions — 82% from exports, 12% from India,
Revenues from clients— Largest client 15% , 64% from top 10 clients
Risks —
Greater dependency on 3rd parties mobile network operations,Rely on 3rd party technology systems and infrastructure
Major revenues from limited client. So high concentration risk, although total clients 2500+.
Risk of potential claims resulting from the client’s misuse of its platform to send unauthorized text messages in violation of TRAI regulations.
Future
May gain from clients consistent need to serve more customers with limited resources
Billable transaction increasing at good rate and most companies pay it in advance
Long term growth seems reasonable and demand seems to increase in coming years
Valuations
Similar to peers in India and less than globally listed peers
Should we apply
High chances of over subscription and less allotment
Possible gains on Listing day can be seen but caution is advised to book profits if any
2+ year holding can give substantial gains if things workout well
Also Read
Happiest Minds IPO crisp summary –heavily subscribed
Rossari biotech IPO detailed summary –It came out with flying colors
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.
The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Happiest minds– approx 9 Yr old company in IT digital services with cloud infrastructure, SaaS, cyber security
Key Service domains – Product engineering services ( approx 50% of revenues), Infrastructure management and security services ( approx 20% revenues), digital business solutions (approx 26%)
Customers — Software development services for independent vendors like Amazon web services, Intel, IBM, Microsoft, Salesforce
Revenues from Key regions — 77% from US, 12% from India, 11% from UK approximately
Revenues from industry — Edutech, hitech and BFSI approx 50% of revenues
Risks —
Promoter have 29% shares pledged as of now
Company wrote of accumulated losses last year
Case for discriminatory employment
Future
May gain from WFH culture in coming years
May gain from cloud related digital services and cyber security services
Valuations – Lower than Mindtree and NIIT,
Should we apply
If you already have something related to digital IT services in your portfolio, you can avoid.
High chances of over subscription and less allotment
Possible gains on Listing day can be seen but caution is advised to book profits if any
Long term growth seems reasonable
Last one Rossari biotech IPO with prediction of 20% gains and good to hold for long term –It came out with flying colors
ROSSARI BIOTECH IPO : Quick analysis